Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07709195
What this trial is testing

Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant

Who this might be right for
Oral MucositisTotal Body IrradiationHematological Malignancies+1 more
Tata Memorial Centre 17
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Early research (Phase 1)Study completedNCT01068301
What this trial is testing

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+2 more
St. Jude Children's Research Hospital 12
Large-scale testing (Phase 3)Looking for participantsNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 138
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Not applicableUnknownNCT06394895
What this trial is testing

Donor Neutrophil Subsets to Predict the Risk of aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Study completedNCT03082677
What this trial is testing

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Myeloid Hematologic MalignancyLymphoid Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT04762875
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Who this might be right for
Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous Leukemia+2 more
Ensoma 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07316595
What this trial is testing

Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

Who this might be right for
HSCTNijmegen Breakage SyndromeTreosulfan Based Conditioning
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588945
What this trial is testing

DaGOAT-Guided Prevention of Severe aGVHD After Allo-HSCT

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 438
Not applicableUnknownNCT04051372
What this trial is testing

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Who this might be right for
Bronchoalveolar Lavage FluidLung Infection
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 250
Testing effectiveness (Phase 2)Study completedNCT01858740
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+15 more
Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)Looking for participantsNCT04314219
What this trial is testing

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) in Complete RemissionAcute Myeloid Leukemia (AML) in Remission
King Faisal Specialist Hospital & Research Center 264
Large-scale testing (Phase 3)UnknownNCT05449899
What this trial is testing

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Secondary Acute Myeloid Leukemia Evolving From MDSAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 232
Testing effectiveness (Phase 2)Study completedNCT01175148
What this trial is testing

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Who this might be right for
Graft vs Host Disease
West Virginia University 60
Testing effectiveness (Phase 2)Study completedNCT01812252
What this trial is testing

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+1 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00052598
What this trial is testing

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT06707493
What this trial is testing

Ivosidenib as Post-HSCT Maintenance for AML

Who this might be right for
IDH1 MutationAcute Myeloid Leukemia (AML)Hematopoietic Stem Cell Transplant (HSCT)
Massachusetts General Hospital 75
Not applicableStudy completedNCT03915249
What this trial is testing

Physical Functions in Allogeneic-HSCT Candidates

Who this might be right for
Stem Cell Transplantation
Gazi University 49
Next Page
64